Mark is a Principal Advisor for Larta Institute. He has years of experience in financial issues & business modeling, IP & market strategy, and strategic business planning. Mark has mentored over 25 entrepreneurs in the fields of energy, medical biotechnology, electronics and IT/software.
Currently, Mark is also a Managing Director with Coronis Medical Ventures, an accelerator and seed fund focused on medical devices. He is an independent consultant and expert advisor on corporate venturing, intellectual property and innovation. He is a Fellow with the Bell-Mason Group, which provides management consulting for corporate innovation best practices. Additionally Mark is an active angel investor, co-founder, and advisor for private companies and serves on the board of several charities. He has served on the board of the National Venture Capital Association (NVCA) and served as Chairman and member of the Executive Committee for the Corporate Venture Group.
Formerly Managing Director of Eastman Ventures, Eastman Chemical Company's corporate venture capital arm, Mark started and led the company's efforts to invest in and partner with private companies providing early access to emerging technology and growth options to Eastman. He and his team forged relationships and co-investments with premier venture capitalists and corporations. Eastman invested with a top-quartile IRR track record in 25 ventures and 5 venture funds in areas spanning IT, life sciences, advanced materials, and clean technology.
Mark earned a BS in Chemical Engineering from Virginia Tech and an MBA in Management from Roosevelt University.